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Conclusion This study demonstrates the feasibility of 
using a single sequence to acquire both high resolution 4D 
CE-MRA and DCE-MRI to evaluate both plaque surface 
morphology and function. The results demonstrate signifi-
cant relationships between lumen surface morphology and 
neovascularization.
Keywords Dynamic contrast enhanced MRI (DCE-
MRI) · Contrast enhanced MR angiography (CE-MRA) · 
Carotid atherosclerotic plaque · Plaque ulceration · 
Neovascularization
Introduction
Stroke is one of the leading causes of death and disability 
worldwide [1] with ischemic strokes accounting for 90% 
of the total reported cases [2]. Twenty percent of ischemic 
strokes are attributed to carotid atherosclerosis [3]. Carotid 
luminal stenosis measured by ultrasound plays an important 
role in screening high risk patients and is the standard crite-
ria for surgical referral [4]. Whilst only patients with severe 
stenosis (≥70%) have shown a benefit from carotid endar-
terectomy (CEA), patients with moderate stenosis (<70%) 
have only shown marginal beneficial effects from surgical 
treatment [5, 6]. There is an increasing recognition that 
other factors, such as plaque surface morphology, may have 
higher predictive value in moderately stenosed plaques [7].
The appearance on X-ray angiography of plaque sur-
face irregularity, or ulceration, has been correlated with 
increased risk of ischemic stroke [8]. This correlation 
applies for both moderate and severe stenosis [8]. Carotid 
ulceration is found to be more common in patients with 
downstream micro emboli [9]. Ulceration has also been 
associated with high risk factors including plaque rupture, 
Abstract 
Objective This study aims to explore the relationship 
between plaque surface morphology and neovasculariza-
tion using a high temporal and spatial resolution 4D con-
trast-enhanced MRI/MRA sequence.
Materials and methods Twenty one patients with either 
recent symptoms or a carotid artery stenosis ≥40% were 
recruited in this study. Plaque surface morphology and 
luminal stenosis were determined from the arterial phase 
MRA images. Carotid neovascularization was evaluated 
by a previously validated pharmacokinetic (PK) modeling 
approach. Ktrans (transfer constant) and vp (partial plasma 
volume) were calculated in both the adventitia and plaque.
Results Image acquisition and analysis was successfully 
performed in 28 arteries. Mean luminal stenosis was 44% 
(range 11–82%). Both adventitial and plaque Ktrans in 
ulcerated/irregular plaques were significantly higher than 
smooth plaques (0.079 ± 0.018 vs. 0.064 ± 0.011 min−1, 
p = 0.02; 0.065 ± 0.013 vs. 0.055 ± 0.010 min−1, 
p = 0.03, respectively). Positive correlations between 
adventitial Ktrans and vp against stenosis were observed 
(r = 0.44, p = 0.02; r = 0.55, p = 0.01, respectively).
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intraplaque hemorrhage and a large lipid-rich necrotic 
core (LRNC) [10], indicating this is a sensitive marker 
of plaque instability [10] and risk of stroke [8, 11, 12]. 
Noninvasive imaging modalities offer high accuracy for 
ulcer detection as well as stenosis measurement [13–15]. 
Among different imaging modalities, contrast-enhanced 
MR angiography provides high resolution imaging allow-
ing visualization of plaque ulceration [13, 16, 17].
In this study we have applied a 4D sequence [18] 
which acquires data suitable for contrast enhanced (CE) 
MRA and dynamic contrast enhanced (DCE)-MRI pro-
cessing. DCE-MRI has been demonstrated as a non-
invasive method to quantify the extent of neovasculature 
within carotid plaques with high accuracy and reproduc-
ibility [19, 20]. Previous studies using DCE-MRI have 
shown that plaque neovascularization is closely associ-
ated with high risk features, such as inflammation [21], 
and is related to ischemic events [22]. In this study, we 
investigated the correlation between plaque surface mor-
phology and neovascularization.
Materials and methods
Experimental methods
The study protocol was reviewed and approved by the 
local ethics committee and written informed consent was 
obtained. Twenty one patients who had a carotid stenosis 
of at least 40% on Duplex ultrasound using NASCET cri-
teria [23] were recruited in total. Ten were symptomatic 
(nine males, mean age 72 years, range 59–86 years) with 
a recent history (less than 6 months) of transient ischemic 
attack (TIA), and 11 were asymptomatic (seven males, 
mean age 78 years, range 68–87 years).
MRI protocol
Imaging was performed on a 3T system (MR750, GE 
Healthcare, Waukesha, WI, USA), using a 4 chan-
nel phased-array neck coil (PACC, MachNet, Roden, 
The Netherlands). The time-resolved imaging of con-
trast kinetics (TRICKS) method [18] was performed to 
obtain 4D CE-MRI with the acquisition resolution of 
0.6 × 0.6 × 1.4 mm3 and the images were interpolated 
into 0.3 × 0.3 × 0.7 mm3 for the DCE analysis. A coro-
nal imaging slab was centered on the carotid bifurcation 
of the higher stenosis degree side. The coronal acquisi-
tion plane was chosen to minimize the inflow artifact 
from the blood, and achieve better longitudinal cover-
age. No spatial saturation was applied. Total acquisi-
tion time was 6 min 23 s, to obtain a mask image and 30 
view-shared phases with a temporal resolution of 10.6 s. 
Coincident with the third phase, a bolus of 0.1 mmol/
kg Gd- DTPA (Gadovist, Bayer Schering, Berlin, Ger-
many) was administered using a power injector at the 
rate of 3 mL/s followed by a 20 mL saline flush. The CE-
MRA data was obtained by subtracting the mask image 
from the multi-phase acquisition. In addition, for plaque 
component determination, the following sequences were 
also performed in the coronal plane: pre- and post-con-
trast 3D  T1-weighted  (T1w) delays alternating with nuta-
tion for tailored excitation (DANTE)-prepared fast spin 
echo [24], 3D time of flight (TOF) and 3D direct throm-
bus imaging (MR-DTI, inversion time of 300 ms) [25]. 
Detailed imaging parameters are listed in Table 1. Total 
scanning time was approximately 30 min.
Image analysis
The  T1w and DCE images were reformatted into the axial 
plane with a 0.7 mm slice thickness using a dedicated 
Table 1  Summary of imaging parameters for the multi-contrast MRI protocol at 3T
TOF time of flight, BB black blood using delays alternating with nutation for tailored excitation (DANTE) preparation, FSE fast spin echo, DTI 
direct thrombus imaging, DCE dynamic contrast-enhanced, MRA MR angiography, TE echo time, TR repetition time, FOV field of view, NEX 
number of excitations
a
 Temporal resolution 10.6 s
Sequence 3D TOF Pre/post-contrast BB  T1w 3D FSE 3D DTI 4D DCE/MRA
Flip angle (°) 20 Variable flip angle 30 20
TE/TR (ms) 2.2/5.9 16.9/540 4.2/8.6 1.5/3.9
FOV (mm × mm × mm) 140 × 140 × 64 140 × 140 × 67 160 × 160 × 66 140 × 140 × 62
Acquired pixel size (mm × mm × mm) 0.5 × 0.5 × 2.0 0.6 × 0.6 × 1.4 1.0 × 1.0 × 1.0 0.6 × 0.6 × 1.4
Reconstruction pixel size (mm × mm × mm) 0.5 × 0.5 × 2.0 0.3 × 0.3 × 0.7 0.3 × 0.3 × 1.0 0.3 × 0.3 × 0.7
NEX 2 2 1 1
Receiver bandwidth (±kHz) 31.25 62.5 25 62.5
Acquisition time 1 min 35 s 2 × 6 min 26 s 4 min 42 s 6 min  23sa
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workstation (AW4.6, GE Healthcare, Buc, France). For 
each patient, the carotid arteries on both sides were ana-
lyzed. Carotid vessel wall and lumen boundaries at each 
slice were manually drawn according to the  T1w images, 
using a DICOM viewer (OsiriX 5.5.2, Pixmeo, Geneva, 
Switzerland). Plaque was defined as a focal wall thickness 
≥1.5 mm [26]. The subtracted CE-MRA image at the fifth 
phase, which had the highest image contrast in the carotid 
artery, was used for morphological analysis. Plaque surface 
morphology was classified as either ulcerated/irregular or 
smooth using the maximum intensity projection (MIP) of 
CE-MRA images, based on previous published standards 
[10], by two experienced reviewers, both having more than 
2 years of experience in carotid imaging. The two review-
ers were blinded to the patients clinical information and 
made their judgement independently. The classification 
result from the first reviewer was used for further analysis. 
Luminal stenosis was measured for each plaque on both 
CE-MRA source image and 3D pre-contrast  T1w images 
separately according to the North American Symptomatic 
Carotid Endarterectomy Trial (NASCET) criteria [23, 
27]. The stenosis measured from CE-MRA source image 
was used for further analysis. This method has a reported 
high intra- and inter-observer reproducibility [8]. IPH was 
defined as bright pixels on the DTI image.
Pharmacokinetic modeling
Images from the 4D data were processed using the Uni-
versity of Washington (Seattle) vasa vasorum imaging 
(VVI) tool [28]. This approach firstly applies a Kalman 
Filtering Registration and Smoothing (KFRS) algo-
rithm, to reduce the noise level in the image and correct 
patient motion [29]. A two-compartment Patlak model 
is then used to generate a parametric map known as the 
“vasa vasorum image (VVI)” showing partial plasma vol-
ume (vp) in shades of red and transfer constant (Ktrans) in 
shades of green. The relationship between blood and tis-
sue signal concentration is modeled as follows:
where Ct and Cp represent the contrast agent concentra-
tion in the tissue and blood plasma, respectively. Lumen 
and wall boundaries manually segmented from  T1w 
images were copied to the VVI. Manual adjustments 
were performed, as necessary to co-register the ROIs 
to the VVIs, by the reviewers who were blinded to the 
final results. Further details of the analysis can be found 
in Kerwin et al. [28]. Adventitial PK measurements were 
calculated by averaging all the pixels along the wall 
boundary. Plaque PK measurements were calculated 
(1)Ct(t) = vpCp(t)+ K trans
t∫
0
Cp
(
t
′
)
dt′
by averaging all the pixels between the wall and lumen 
boundary. The overall PK parameters of each plaque 
were calculated as the mean value across all the plaque 
containing slices. To test the interrater reproducibility of 
this method, two reviewers preformed the analysis inde-
pendently for all of the patients.
The PK parameter differences were evaluated using 
linear and non-linear assumptions of the signal intensity 
and Gd concentration. The following equations were used 
to calculate the Gd concentration:
where Eq. (2) calculates the pixel T1 value accord-
ing to its signal intensity based on the spoiled gradient 
echo sequence [30]. α is the flip angle and M0 is a con-
stant value. Equation (3) calculates the Gd concentra-
tion (mmol/L) according to the pixel T1 changes. T1 and 
T1,0 (s) are the current and native pixel T1 values (blood 
T1,0 = 1500 ms and vessel wall T1,0 = 1000 ms from the 
literature value [31] were used). The corrected Gd con-
centration was then applied again to the 28 arteries using 
Eq. (1). The calculated PK parameters were then com-
pared with the results from the linear assumption.
Statistical analysis
The statistical analysis was performed using R (version 
3.2.2). The Shapiro–Wilk’s test was used to test nor-
mality assumptions. The Kappa statistic was performed 
to evaluate interrater agreement in ulceration detec-
tion. The Student’s t test was used to compare the PK 
parameters for smooth versus ulcerated/irregular plaques 
defined by the first reviewer, and also to compare hem-
orrhage and non-hemorrhage plaques. Pearson’s corre-
lation was used to assess the relationship between PK 
parameters and luminal stenosis. The concordance cor-
relation coefficient (CCC) was reported to assess the 
relationship between the stenosis measured by CE-MRA 
and 3D  T1w images. The CCC and Bland–Altman plots 
were used to compare the differences between linear 
and non-linear assumptions of image signal and Gd con-
centration. The inter-rater agreement in PK parameters 
was assessed using the intraclass correlation coefficient 
(ICC). A Chi-squared tests was used to compare propor-
tions of patients with IPH. Parametric distributions were 
presented as mean ± SD. p values <0.05 were consid-
ered statistically significant.
(2)I = M0
sin (α)
(
1− e
−
TR
T1
)
1− cos (α)e
−
TR
T1
e
−
TE
T
∗
2
(3)r[Gd] =
1
T1
−
1
T1,0
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Results
Of the 21 patients, three patients did not finish the exam-
ination due to discomfort, four carotid arteries were 
excluded from data analysis due to motion artefacts and 
four arteries were excluded due to occlusion. The rest of 
the images were of diagnostic quality, and used for fur-
ther analysis. Atherosclerotic plaques were identified in 
the remaining 28 arteries, with a mean luminal stenosis 
of 44% (range 11–82%). Fourteen plaques were classi-
fied as ulcerated/irregular and fourteen were classified 
as smooth. In the 28 arteries analyzed, two independent 
reviewers agreed in 26 (93%) cases for plaque surface 
morphology classification (κ = 0.79; 95% CI 0.56–1.00). 
The PK parameters (Ktrans and vp in adventitia and plaque) 
were normally distributed (p > 0.05). For the luminal ste-
nosis, the correlation between CE-MRA and 3D  T1w was 
good (r = 0.89).
The images in Fig. 1 are from a symptomatic patient, 
with a 52% stenosis on the right side. The plaque contains 
a large intraplaque hemorrhage (IPH). Figure 1c shows 
the intra-luminal and adventitial signal change with time 
following contrast agent administration. Figure 2 is from 
the same artery and shows the multi-contrast MR images 
and calculated VVI. An ulceration can be clearly seen on 
the CE-MRA images, but is not so apparent on the 3D 
TOF-MRA. Surface irregularity can be observed in both 
pre- and post-contrast  T1w images. The MR-DTI shows a 
large region of IPH. The VVI shows regions of high Ktrans 
around the ulceration and at the adventitia boundary, with 
a relatively low Ktrans inside the IPH, which is in agree-
ment with a previous study [32].
The PK values from the linear assumption were used 
for the statistical analysis. Adventitial and plaque Ktrans 
in ulcerated/irregular plaques were significantly higher 
compared to smooth plaques (Fig. 3a, b, adventitial Ktrans 
0.079 ± 0.018 vs. 0.064 ± 0.011 min−1, p = 0.02; plaque 
Ktrans 0.065 ± 0.013 vs. 0.055 ± 0.010 min−1, p = 0.03, 
respectively). Whilst vp demonstrated no significant differ-
ence between groups (Fig. 3c, d, adventitial vp 9.3 ± 5.3% 
Fig. 1  a Shows DCE images 
at different time frames at a 
single slice location within an 
ICA branch of the plaque. The 
dashed red and green lines in 
frame 5 show the boundary of 
carotid lumen and adventitia. 
b Shows the corresponding 
black blood  T1w image with 
red and green lines delineating 
the lumen and wall boundary. 
c Represents the mean signal 
intensity time course within 
the lumen (red) and adventitia 
(green)
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vs. 9.8 ± 4.8%, p = 0.81; plaque vp 13.5 ± 5.5% vs. 
11.8 ± 4.9%, p = 0.32, respectively).
Positive correlations between adventitial Ktrans and 
vp with the degree of stenosis were observed (Fig. 4a, b, 
r = 0.44, p = 0.02 for adventitial Ktrans; r = 0.55, p = 0.01 
for adventitial vp, respectively). While no significant cor-
relation was observed for plaque Ktrans or vp with stenosis 
(Fig. 4c, d, r = 0.23, p = 0.24 for plaque Ktrans; r = 0.12, 
p = 0.55 for plaque vp, respectively).
The CCC comparing the linear and non-linear assump-
tions for adventitial Ktrans, plaque Ktrans, adventitial vp and 
plaque vp were: 0.95, 0.93, 0.99 and 0.99, respectively. 
There was highly significant concordance between the lin-
ear or non-linear assumptions (all p < 0.001), though there 
is a significant bias in PK values when using the linear and 
non-linear assumption of image signal to Gd concentration. 
Figure 5 demonstrated the Bland–Altman plots comparing 
both assumptions.
IPH was found in eight plaques. Within this group, six 
arteries had ulcerated plaques and two had smooth plaques. 
In the 20 plaques without IPH, we noted that smooth 
plaques were more common (12 had smooth plaques), how-
ever, these respective proportions were not significantly 
different (p = 0.28). Plaques with hemorrhage have higher 
mean adventitial Ktrans values compared with plaques with 
no hemorrhage (0.078 ± 0.019 vs. 0.069 ± 0.015 min−1), 
however the difference here was not significant (p = 0.2).
The agreement for the four measured DCE param-
eters between the two reviewers was good. The ICC for 
adventitial Ktrans, plaque Ktrans, adventitial vp and plaque vp 
are 0.88, 0.93, 0.81 and 0.71, respectively.
Discussion
To the best of our knowledge, this is the first application 
of a 4D sequence to acquire both high spatial and temporal 
resolution DCE-MRI and CE-MRA of the carotid artery, 
allowing for combined morphological and functional 
assessment of carotid atherosclerosis from a single contrast 
administration. The results show that adventitial and plaque 
Ktrans were higher in ulcerated/irregular plaques compared 
to smooth plaques. Adventitial Ktrans and vp were also posi-
tively correlated with the degree of luminal stenosis.
Carotid plaque ulceration, characterized as an intimal 
defect with the intraplaque component exposed to the lumen 
[9], can form emboli and thrombosis leading to ischemic 
neurologic symptoms. Sitzer et al. showed plaque ulceration 
and lumen thrombus are the main sources of cerebral micro-
emboli [9]. Multiple studies have also shown that plaque 
ulceration is associated with cerebral infarcts, TIA and 
amaurosis fugax [8, 11]. In this study, plaque enhancement 
could be observed in both smooth and ulcerated plaques and 
the derived VVI showed significant differences in PK param-
eters between both of these plaque types. The results dem-
onstrate that ulcerated plaques are more prevalent to neovas-
cularization and possibly inflammation. Plaque ulceration or 
fibrous cap discontinuity may induce more inflammatory cell 
Fig. 2  An ulcerated plaque in the multi-contrast MR protocol, 
including MIP from CE-MRA, oblique and axial reformat of CE-
MRA, TOF-MRA,  T1w, DTI, CE-T1w and VVI. The white arrow in 
CE-MRA suggests the ulcer arises perpendicularly from the lumen. 
The ulcer can be clearly seen on the CE-MRA images, while it is not 
clearly visible on the TOF-MRA images. The pre-contrast  T1w image 
shows the lumen surface irregularity, and a thin or ruptured FC can 
be seen on the post-contrast  T1w images (black arrow). The hyper-
intense area on MR-DTI represents a large intraplaque haemorrhage/
thrombus (white arrow). The VVI has the range of vp from 0 to 65% 
and Ktrans from 0 to 0.5 min−1 which shows a high Ktrans region at the 
adventitia
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infiltration into the plaque, which in turn further weakens the 
fibrous cap and eventually causes the plaque to rupture. This 
suggests quantitative analysis of DCE-MRI could provide 
more information than conventional contrast-enhanced mor-
phological images in identifying lesions at higher risk.
While only adventitial Ktrans and vp are correlated with 
luminal stenosis, no significant correlation was observed 
between whole plaque PK values and the stenosis. This 
might be due to a lower sensitivity as a result of aver-
aging PK parameters across the whole plaque region. 
While various plaque components such as IPH, lipid 
core and fibrous tissue have different PK values [32], 
simple averaging of PK parameters across the plaque 
region may be insufficient for quantitative analysis and 
risk stratification. A positive correlation between lumi-
nal stenosis and adventitial Ktrans and vp was observed in 
this study (Fig. 4a, b), indicating a relationship between 
plaque growth and adventitial neovascularization. These 
microvessels within the atherosclerotic lesion have 
shown close association with inflammatory cells [33] 
which indicate that these could serve as a pathway for the 
macrophage entry into the plaque that leads to chronic 
inflammation hence promoting plaque development.
The presence of intraplaque hemorrhage (IPH) has also 
been found to be associated with increased adventitial Ktrans 
[34]. In our study, plaques with IPH had higher adventitial 
Ktrans, however the difference was not significance. The rea-
son for this may due to lack of statistical power, as only a 
small number of plaques (eight) contained IPH. Although 
the exact etiology of the IPH is still unclear it is suggested 
that most likely the rupture of fragile and leaky neovessels 
that vascularize the developed plaque leads to IPH [35].The 
histopathological evidence also supports the relationship of 
IPH to the presence of neovessels [36]. In our study, IPH 
was absent in most of the plaques. The correlation between 
PK parameters and surface morphology also applies to the 
plaques without IPH, indicating ulceration and a high degree 
of stenosis were two other factors, apart from IPH, which 
could present with increased plaque neovascularization and 
inflammation.
Fig. 3  Comparison of pharma-
cokinetic parameters in smooth 
and ulcerated/irregular plaque
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Fig. 4  a Shows the significant 
correlation between stenosis and 
adventitial Ktrans. b Shows the 
significant correlation between 
stenosis and adventitial vp. 
There is no significant correla-
tion between plaque Ktrans or vp 
and stenosis (c, d)
Fig. 5  Bland-Altman plots of the PK parameters derived after model-
ling the linear and non-linear relationships of signal intensity and Gd 
concentration. There is a significantly bias in PK values when using 
linear and non-linear assumption of image signal to Gd concentration. 
Note that K trans
1
 and vp1 represent the linear model, and K trans2  and vp2 
represent the non-linear model
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The use of multi-contrast MRI allows for detailed analy-
sis of plaque composition and vulnerability assessment, 
which could provide more insight than simple luminal ste-
nosis measurements [37]. This study demonstrates that a 
combined 4D DCE-MRI/MRA acquisition in combination 
with multi-contrast 3D sequences can aid in the identifica-
tion of high-risk plaque features. Our study also demon-
strates that these features can be obtained in a clinically 
acceptable scan time of approximately 30 min.
There are several limitations in this study. Firstly, no 
histological validation was performed on the plaques. 
However the correlation between DCE-MRI and neovascu-
larization as well as inflammation has been demonstrated 
in previous studies [19, 21, 28], and CE-MRA is consid-
ered reliable for observing plaque surface morphology 
[13, 16]. The second limitation is that only a small patient 
cohort was included in this study. As discussed above, the 
Ktrans difference between IPH groups was not significant, 
this might be due to the resultant lack of statistical power. 
Thirdly, the view-ordering used in this study could smooth 
the temporal information, especially during the injection 
period. However, this is not considered to be a significant 
effect and other studies have used similar analysis for vari-
ous DCE applications, including breast [38, 39], prostate 
[40] and also animal models [41]. The last limitation is that 
a thick coronal imaging slice (1.4 mm) was used in this 
study. This might bring errors in calculating the PK values 
for the thin vessel wall. Future protocol design could con-
sider increasing axial resolution for a more precise analysis.
Conclusion
This study investigated the relationship between PK mod-
eling with carotid plaque surface morphology by simulta-
neously acquiring 4D DCE-MRI and CE-MRA. Adventitial 
and plaque Ktrans from DCE-MRI analysis is significantly 
higher in ulcerated plaques than smooth ones. Also, adven-
titial Ktrans and vp are correlated with luminal stenosis.
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